Drug Type Small molecule drug |
Synonyms Donepezil/Nebivolol, 多奈哌齐/奈必洛尔 |
Mechanism AChE inhibitors(Acetylcholinesterase inhibitors), β1-adrenergic receptor antagonists(Beta-1 adrenergic receptor antagonists) |
Active Indication |
Inactive Indication- |
Originator Organization Dr. Noah Biotech Co., Ltd.Startup |
Active Organization Dr. Noah Biotech Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (US) |
Molecular FormulaC22H26ClF2NO4 |
InChIKeyJWEXHQAEWHKGCW-UHFFFAOYSA-N |
CAS Registry169293-50-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Preclinical | US | Dr. Noah Biotech Co., Ltd.Startup | 28 Sep 2023 |